Rhumatologie

Adverse events associated with Rofecoxib therapy : results of a large study in community-derived. Osteoarthritic patients

Drug Safety Bannwarth B, Trèves R, Euller-Ziegler L, Rolland D, Ravaud Ph, Dougados M.

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Impact of disease activity for patients with axial spondyloarthritis
Rhumatologie

Impact of disease activity for patients with axial spondyloarthritis

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis
Rhumatologie

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France
Rhumatologie

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France